Allergy Relief D tablets recalled for failed dissolution specifications
Dr. Reddy's Laboratories is recalling Allergy Relief D extended-release tablets distributed nationwide by Walmart due to failed dissolution specifications. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class III recall, which means the violation is unlikely to cause adverse health consequences. No illnesses or injuries have been reported. The hazard is a manufacturing quality issue affecting dissolution and potentially medication efficacy, not a direct safety threat.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Allergy Relief D Extended-Release Tablets containing Fexofenadine HCL 60mg (antihistamine) and Pseudoephedrine HCL 120mg (nasal decongestant). The product was distributed nationwide by Walmart Inc. in 20-count and 30-count packages.
The recall is due to failed dissolution specifications, meaning the tablets do not dissolve at the specified rate. This manufacturing defect may affect proper absorption and effectiveness of the medication. The FDA has classified this as a Class III recall.
The affected lot numbers are AC2203133B and AC2203133A, both expiring January 2024. Consumers who have this product should stop using it and contact their pharmacist or healthcare provider for guidance on obtaining a replacement medication.
The recalled product
- Product
- Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug
- Hazard
- dissolution-failure
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot# (a) AC2203133B
- EXP 01/2024
- (b) AC2203133A
- EXP 01/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27